These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14755681)

  • 1. Par-4 inducible apoptosis in prostate cancer cells.
    Gurumurthy S; Rangnekar VM
    J Cell Biochem; 2004 Feb; 91(3):504-12. PubMed ID: 14755681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutually exclusive expression patterns of Bcl-2 and Par-4 in human prostate tumors consistent with down-regulation of Bcl-2 by Par-4.
    Qiu G; Ahmed M; Sells SF; Mohiuddin M; Weinstein MH; Rangnekar VM
    Oncogene; 1999 Jan; 18(3):623-31. PubMed ID: 9989812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cancer cell survival by Par-4.
    Ranganathan P; Rangnekar VM
    Ann N Y Acad Sci; 2005 Nov; 1059():76-85. PubMed ID: 16382046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of Par-4 leads to induction of apoptosis in CNS tumor cell lines.
    Vetterkind S; Boosen M; Scheidtmann KH; Preuss U
    Int J Oncol; 2005 Jan; 26(1):159-67. PubMed ID: 15586236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.
    Kukoc-Zivojnov N; Puccetti E; Chow KU; Bergmann M; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E; Boehrer S
    Exp Hematol; 2004 Jul; 32(7):649-56. PubMed ID: 15246161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells.
    Srinivasan S; Ranga RS; Burikhanov R; Han SS; Chendil D
    Cancer Res; 2007 Jan; 67(1):246-53. PubMed ID: 17185378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of the proapoptotic protein Par-4 in normal rat tissues.
    Boghaert ER; Sells SF; Walid AJ; Malone P; Williams NM; Weinstein MH; Strange R; Rangnekar VM
    Cell Growth Differ; 1997 Aug; 8(8):881-90. PubMed ID: 9269897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.
    Brieger A; Boehrer S; Schaaf S; Nowak D; Ruthardt M; Kim SZ; Atadja P; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
    Biochem Pharmacol; 2004 Jul; 68(1):85-93. PubMed ID: 15183120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
    Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate apoptosis response gene-4 sensitizes neoplastic lymphocytes to CD95-induced apoptosis.
    Bergmann M; Kukoc-Zivojnov N; Chow KU; Trepohl B; Hoelzer D; Weidmann E; Mitrou PS; Boehrer S
    Ann Hematol; 2004 Oct; 83(10):646-53. PubMed ID: 15316756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential control of apoptosis by DJ-1 in prostate benign and cancer cells.
    Hod Y
    J Cell Biochem; 2004 Aug; 92(6):1221-33. PubMed ID: 15258905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
    Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
    Ye L; Kynaston H; Jiang WG
    Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.
    Li T; Li D; Sha J; Sun P; Huang Y
    Biochem Biophys Res Commun; 2009 Jun; 383(3):280-5. PubMed ID: 19302977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma.
    Cook J; Krishnan S; Ananth S; Sells SF; Shi Y; Walther MM; Linehan WM; Sukhatme VP; Weinstein MH; Rangnekar VM
    Oncogene; 1999 Feb; 18(5):1205-8. PubMed ID: 10022126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer.
    Zhang X; Jin TG; Yang H; DeWolf WC; Khosravi-Far R; Olumi AF
    Cancer Res; 2004 Oct; 64(19):7086-91. PubMed ID: 15466204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtoxic concentration of doxorubicin enhances TRAIL-induced apoptosis in human prostate cancer cell line LNCaP.
    Kang J; Bu J; Hao Y; Chen F
    Prostate Cancer Prostatic Dis; 2005; 8(3):274-9. PubMed ID: 15897917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression and intracellular localization of prostate apoptosis response-4 (Par-4) are associated with apoptosis induction in nasopharyngeal carcinoma cell lines.
    Lee JW; Lee KF; Hsu HY; Hsu LP; Shih WL; Chu YC; Hsiao WT; Liu PF
    Cancer Lett; 2007 Nov; 257(2):252-62. PubMed ID: 17881119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria from TRAIL-resistant prostate cancer cells are capable of responding to apoptotic stimuli.
    Liang Y; Eid MA; Lewis RW; Kumar MV
    Cell Signal; 2005 Feb; 17(2):243-51. PubMed ID: 15494215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.